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Summary
Five islet-reactive T cell clones were established from islet-infiltratingT cells ofnon-obese diabetic
(NOD) mice. All clones expressed CD4, but notCD8, and responded to islet cells from various
strains of mice in the context of I-ANOD. They could induce insulitis when transferred into
disease-resistant I-E+ transgenicNOD mice. The T cell receptor (TCR) sequences utilized by
the clones were determined . Their usage ofTCR V and J segments was not restricted but was
rather diverse. One of the clones utilizedV#16 . The expression ofV#16 was significantly reduced
in I-E+ transgenic NOD, suggesting the possibility that the islet-reactive T cell clone expressing
V#16 may be deleted or inactivated by I-E molecules . This clone might be one of the candidates
that triggers insulitis .
T
he non-obese diabetic (NOD)' mouse spontaneously
develops insulin-dependent diabetes mellitus (IDDM)
after T cell-mediated autoimmune insulitis (1-5) . Several reces-
sive genes are known to determine disease susceptibility (6,
7) . One of these genes is closely linked to the MHC class
II region characterized by the unique structure of I-A and
the lack of I-E (6, 8) . Recent work in I-A or I-E transgenic
NOD mice (9-13) demonstrated that both the unique
I-ANOD molecule and the lack of I-E expression are crucial
in development of the autoimmune insulitis and diabetes.
Therefore, theNOD mouse can be an ideal model to eluci-
date the role ofMHC class Il in generation ofautoimmune
T cells. Recently, a limited heterogeneity ofTCR repertoire
has been demonstrated in autoreactive T cells responsible for
experimental autoimmune encephalomyelitis (EAE) (14, 15).
However, it is still controversial whether the finding obtained
from experimental autoimmune models is generalizable to
spontaneous autoimmune diseases in mice and humans. In
this study, CD4+ islet-specific T cell clones were established
from pancreatic islet-infiltrating cells ofNOD mice, and the
TCR sequences of these clones were determined . The usage
ofV andJ gene segments was not restricted, but was diverse,
which is in contrast to experimentally induced EAE . Some
of T cell clones were distinguishable by bearing V#12 and
V016 gene segments known to be deleted in I-E-expressing
mice. Their possible roles in the development of insulitis are
discussed .
'Abbreviations used in this paper . EAE, experimental autoimmune en-
cephalomyelitis ; IDDM, insulin-dependent diabetesmellitus ; MBP, myelin
basic protein ; MS, multiple sclerosis; NOD, non-obese diabetic .
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Materials and Methods
Islet-reactive T Cell Clones.
￿
Islet-reactive T cell clones were es-
tablished from infiltrating T cells within islets isolated from 7-11-
wk-old NOD mice. Isolated islets were cultured in RPMI 1640
containing 2% NOD serum for 1 wk in the presence of irradiated
(3,000 rad) NOD spleen cells . During this period, most of the
infiltrating cells died. Surviving cells were then cultured inRPMI
1640 containing 10% FCS and 20% culture supernatant ofCon
A-stimulated spleen cells, and the cells expanded were further stimu-
lated with irradiated islet cells andNOD spleen cells without cul-
ture supernatant of spleen cells . These cell lines were cloned by
limiting dilution and only the clones reactive against islet cells in
the presence ofNOD APC were selected . The reactivity of each
T cell clone was assayed by stimulation of 104 rested T cells with
104 irradiated (3,000 rad) islet cells as antigens and 5 x 105 irradi-
ated (3,000 rad) spleen cells as APC . After a 72-h incubation, cells
were pulsed with 0.5 P.Ci [3H]TdR for 12 h . [3H]TdR incorpora-
tion was measured by a liquid scintilation counter and is expressed
as the mean of duplicate cultures.
In Vivo Transfer ofIslet-reactive T Cell Clones.
￿
I-E* NOD mice
(8-10 wk old, female) were sublethally irradiated (650 rad) and
were transferred with 2-5 x 106 cells of islet-reactive T cell clones
intravenously . After 2 wk, another injection with 2-5 x 106 cells
ofT cell clones was given, and recipient mice were killed 2 wk
later after the second transfer for histological examination of
pancreas .
Isolation andSequencing ofTCR .
￿
TotalRNA was isolated from
the cells of each clone using a standard. (guanidine isothiocyanate/
CsCl) method . ComplementaryDNA for each TCR ct and0 were
synthesized from total RNA (0.3-1 ug) in a 25-P.1 reaction mix-
ture containing 0.5 mM dNTPs, 200 UMo-MLV reverse transcrip-
tase (Bethesda Research Laboratories, Bethesda, MD), 2 U human
placenta ribonuclease inhibitor (Takara, Kyoto, Japan), and 100pmol
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AGAC (specific to Ca) andCB-2TGGCCAAGCACACGAGGG-
TAGCC (specific to CS) . A poly(dA) tail sequencewasthen intro-
duced with terminal deoxynucleotidyl transferase (Bethesda
Research Laboratories) . Amplification wasperformedwith thermus
thermophilus HB8 DNA polymerase (Toyobo Co., Ltd., Osaka,
Japan) . The first PCR was done with primers T7dT17, TAA-
GATCTAATACGACTCACTATAGGGAAGCTTTTTTTTTTTT
TTTTT, and CA-2 or CB-2 with 30 cycles ofdenaturing at 94°C
for 1 min, annealing at 45°C for 1 min, and extension at 74°C
for 2.5 min . 40 gl out of 100 pl PCR product was loaded onto
1% low-melting agarose gel; positions of 400-600 by were cut
out . The size-selected gel was melted, and 15 Ftl of the melted gel
was subjected to the secondary PCRusing the same primers and
conditions as in the first one except for the higher annealing tem-
perature (50°C) . Theproduct was size selected again andthe final
PCR was done with ST7 primer, TCTAAGTCGACTCACTAT
AGGGAAGC, and internal constant region specific primers contain-
ing restriction sites, CA1*,CCGAGCTCCGAGGATCTTTTAA-
CTGGTACAC (specific to Ca) ; or CB-I*, TCGAGCTCTGAT
GGCTCAAACAAGGAGAC (specific to Chi) . The annealing tem-
perature for the final PCR was 55°C, and the rest of conditions
were identical to the first PCR. After 40-45 cycles, a sharpband
-600 by was observed . The final product was digested with Sacl
and Sall, and cloned into the PUC18 vector. In some cases, the
products were digested only with Sall since the Sacl site was found
in the middle of theV regions. Transformed Escherichia coli colo-
nies were screened with further internal constant region specific
oligonucleotides; CA-0, AGGTTCTGGGTTCTGGATGTT (spec-
ific to Ca); or CB-0,GGTGGAGTCACATTTCTCAGAT (specific
to CO) . Plasmid DNAs were prepared from positive colonies, and
alkali-denaturedDNAs were sequencedby dideoxy chain termina-
tion method using aSequenase' Ver.2 kit (United States Biochem-
ical Corp., Cleveland, OH) according to the manufacturer's in-
struction .
RNA Blot Analysis. Spleen cells from NOD, I-E* NOD,
BALB/c, and C57BL/6 (B6) mice were cultured at 2 x 106/ml
for 48 h with Con A (5 lAg/ml) . Poly(A)+ RNA was prepared
from total RNA with an oligo(dT) cellulose column . 5 I~g of
poly(A)* RNA obtained from each spleen cell culture was loaded
onto an agarose gel and transferred to a nylon filter. RNA blots
were hybridized with "P-labeled probes specific to VS8.2, V012,
VS15, V016, and C/3 . Probes for these V0 gene segments were
synthesized by PCRusingTCR S chain genes oftheT cell clones
as templatesand V(3 gene-specific oligomers and aT7 as primers .
Three individual filters were first hybridized with probes forVS12,
V015, and V016 . They were dehybridized andrehybridized with
the constant region probe (CS) . Then, the filter used for V016
was also rehybridized with a V08.2 probe .
Results and Discussion
We first analyzedTCRVa gene usage in peripheralTcells
from NOD mice of various ages and in islet-infiltrating T
cells by using available mAbs to V0 gene products. The ex-
pression pattern of analyzedVO gene segments in peripheral
T lymphocytes did not change before and after the onset of
insulitis and diabetes (data not shown) . TheTCRV0 gene
usage in the locus of insulitis wasalmost comparable to that
in peripheral T cells except that the proportion of V03-
expressing T cells was a little higher in infiltrating T cells
than in peripheral T cells . For instance, in 15-wk-oldNOD
mice, mean percentages of V03+, Va5+, VS6+, V08+,
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V09+, and V011+ cells were 1.29, 2.89, 8.90, 28.9, 2.18,
and7.67% in islet infiltrating T cells, and0.503, 3.17, 8.42,
29.3, 1.57, and6.54% in inguinal and axillary lymph nodes,
respectively. Although we do not know whether an increase
ofV03+ cells in islet-infiltrating T cells is significant or not,
the result indicates that islet-infiltratingTcells are rather het-
erogeneous in terms of V(3 gene usage .
However, theTCR repertoire of islet-infiltrating T cells
maynot necessarily reflect that of autoreactiveTcells respon-
sible for the development of insulitis. Islet-reactiveTcell lines
were therefore established by stimulation ofinfiltratingTcells
with islet cells in thepresence ofirradiatedNOD spleen cells
as APC. All theseT cell lines were found to express CD4
(data not shown) and were further cloned by limiting dilu-
tion. The specificities of these clones were then analyzed by
using islet cells andAPC from various strains of mice, in-
cluding I-Eexpressing transgenic NOD mice that had previ-
ouslybeen demonstrated not to develop insulitis (9, 10, 13) .
Fig. 1 shows the reactivity of a representative T cell clone,
4-1-L.6, to islet cells. This clone showed a strong reactivity
to islet cells in the presence of splenocytes from NOD or
I-E+ NOD as APC. Its inability to respond to islet antigens
presented by APC from either BALB/c (H-2d) or C57BL/6
(H-2b) indicates that the clone is presumably restricted to
class II I-A but not to class I, since the haplotypes ofH-2K
and -D ofNOD are d and b, respectively. Furthermore, the
a chain of I-ANOD is identical to that of BALB/c, indicating
that the unique structure of A#NOD determines the I-A re-
striction of this clone. Islet cells from allogeneic mice such
as BALB/c can also stimulate the clone in the presence of
APC from NOD or I-E+ NOD. In addition, NOD insu-
linoma cells derivedfrom aRIRTAG2 transgenicNODmouse
(16), which carries the SV40 largeT antigen gene under the
control ofinsulinpromoter as a transgene, could also induce
Figure 1.
￿
Islet reactivity andMHC specificity of a T cell clone (4-1-
L.6) established from NOD pancreatic islet-infiltrating cells. Cloned T
cells (4-1-L .6) were cultured without antigen (open ban), withNOD islet
cells (dotted ban), or with BALB/c islet cells (filled bars) in the presence
or absence ofAPC from C57BL/6, BALB/c, NOD, or I-E* NOD for
3 d . After a 72-h culture, cells were pulsed with [3H]TdR for 12 h, and
[3H]TdR incorporation was measured.Figure 2 .
￿
Islet-reactive T cell clones can transfer insulitis into I-E-transgenic NOD mice. Pancreatic sections of an irradiated I-E" NOD mouse
without transfer (a) or with transfer of an islet-reactive T cell clone, 4-1-G.4 (b), were shown. I-E * NOD mice (8-10wk old, female) were sublethally
irradiated (650 rad) and were transferred with 2-5 x 106 cells of the islet-reactiveT cell clone intravenously. After 2 wk, another injection with 2-5
x 106 T cell clones was given, and recipient mice were killed 2 wk later after the second transfer.
proliferation of the clone (data not shown), indicating that
it reacts to an antigenic determinant on a cells . The other
T cell clones showed essentially the same reactive pattern (data
not shown) . The results indicate that all these T cell clones
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are reactive to (3 cell antigens in the context ofNODMHC
class II (I ANOD) but that S cell antigens stimulating the
clones are not unique to the NOD mouse . It is also notable
that APC from I-E+ NOD mice can also present islet an-tigens to these clones, suggesting that inhibition of insulitis
in I-E+ NOD does not take place at the level of antigen pre-
sentation.
These T cell clones were tested for their ability to induce
the insulitis. We used I-E+ NOD mice as. the recipients
since these mice never develop insulitis but have the identical
genetic background to NOD except for the Ead transgene.
These mice are also useful to determine whether any sup-
pressive mechanisms in the effector phases are involved in I-E-
mediated prevention of insulitis. Each clone maintained under
the stimulation of islet cells with NOD APC was expanded
with 11,2 for a few days and then injected intravenously into
sublethally irradiated I-E+ NOD recipients. The recipients
received another injection of the same T cell clone 2 wk later
and were tested for the development of insulitis 4 wk after
the first injection. A typical pancreatic section is shown in
Fig. 2. We could observe lymphocyte infiltration within islets
in all the mice that received the T cell clones, although there
still exist intact islets. This result demonstrates that all the
clones could transfer insulitis in I-E transgenic NOD mice,
and indicates that the islet-reactive T cells were not suppressed
in I-E+ NOD mice.
a
Clone
￿
Va Junctional
diversity
4-1-L.6 TGCGCACTGGAG GGCCAT
C A L E G 8
Va13
4-1-1t .1 TGTATCCTGAGA
C I L R
Va6.1
4-1-G.4 TGTGCAGCACCC TCGAAC
C A A P S N
Va2.2
4-1-E.2 TGTGCAGTGGCA GGA
C A V A G
Val .l
7-10-D .3 TGTGCAGTGAGC CCG
C A V S P
Val . l
4-1-L .6 TGCGGTGCT AGGGGCACT
4-1-1C .1 TGTGCCAGC GGTGGG
C A S
￿
G G
VP8 .2
4-1-G.4 TGTGCCAGCAGC TTAGGGACA
C A S S
￿
L G T
VP16
4-1-R.2 TGTGCCAGC AGACTGGGA
C A S
￿
R L G
Vp12
7-10-D .3 TGTGGTGCT GGACAGGGG
C G A
￿
G Q G
V015
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T N T G Q
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TCR sequences of each T cell clone were analyzed. cDNA
was synthesized from total RNA ofeach clone by usingcon-
stant region-specific primers, and a poly(dA) tail sequence
was introduced in the 3' terminal of each cDNA. The se-
quences containing Va or VO and joining regions were
amplified by PCR, and the sequences of TCR of each clone
were determined. The usage ofTCR V and J gene segments
of five individual T cell clones is summarized in Fig. 3. Four
Vas (W13, Va6.1, Va2.2, and Val.1) and four Vfls (VO15,
V016, V012, and V08.2) were utilized by these five clones.
Va1.1 was utilized by two clones, 4-1-E.2 and 7-10-D.3, and
V015 by two clones, 4-1-L.6 and 7-10-D.3. Predominant usage
of certain combinations of Va, VO, Ja, and Ja has been
reported for T cells specific for cytochrome C (17, 18) and
myelin basic protein (MBP) (14, 15). Amino acid sequences
in thejunctional regions equivalent to CDR3 of Ig are known
to be selected in T cells with certain fine specificities (19,
20). However, in the present case, particular pairs of Va and
V(3 segments were not shared by more than two islet-reactive
T cell clones. Junctional regions in TCR of these clones were
also variable in each clone, as shown in Fig. 3. Thus, our
results indicates that TCR usage of islet-reactive T cells is
TATGGGGGCAGTGGC
Y G G S G
TT11
ACGGGTTACCAGAAC
T G Y Q N
El
GGTGCAGATAGACTC
G A D R L
TA80
GGATACAACAAACTC
G Y N It L
D3
Jp
TATGAACAGTACTTC
Y E Q Y r
J02.7
TATGAACAGTACTTC
Y ti Q Y r
JP2 .7
J02.2
AACCAAGACACCCAG
N Q D T Q
Jp2.5
GGAAATACGCTCTAT
G N T L Y
Figure 3.
￿
Five independent islet-reactive T cell clones
ofthe NOD mouse utilizedistinctcombinations ofTCR
Vc4 Ja, V(3, and J0. Sequences ofjunctional regions of
TCRachain (a) and 0chain (b) ofeachclone were shown.
TCR sequences containing Va and Ja or V/3 andJRwere
amplified from all T cell clones by PCR (see Materials
and Methods) and determined by a dideoxy termination
J(31 .3 method.not limited, but heterogeneous, and that multiple antigenic
determinants on S cells may contribute to their generation
or activation . Islet-specific T cell clones reported by Haskins
et al . (21) also showed various specificities to islet cells of
different sources, suggesting that multiple antigenic deter-
minants may be recognized .
In an experimentally induced autoimmune model, EAE,
the repertoire ofthe autoreactiveT cells isknown to be limited .
The V08.2 and Vo14 segments were dominantly utilized by
MBP-specific T cells in H-2° mice such as PL/J and B10.PL
(14, 15), while V017a was frequently observed in H-2g mice
such as SJL/J (22) . It has recently been reported that MBP-
specific T cell clones generated either from multiple sclerosis
(MS) patients or control subjects predominantly expressed
certain VO gene segments (23). Limited heterogeneity ofTCR
Vci gene expression was also reported in T cells from demy-
elinating brain plaques inMS patients (24) . Our present finding
is in contrast to these previously reported. There are two pos-
sibilities : (a) unlike EAE or MS, multiple antigenic deter-
minants may be involved in the establishment of autoimmune
insulitis inNOD mouse; or (b) although multiple antigenic
determinants may be recognized by these clones, one or a
few ofthemmay be the diabetogenic targets that trigger au-
toimmunity while the rest of the autoreactive T cells may
be secondarily generated and responsible for progression of
insulitis and diabetes mellitus . Previous experiments showing
prevention of insulitis in I-E transgenic NOD mice (9, 10,
13)may support the latter possibility for the following reasons.
All the T cell clones that we established reacted to islet cell
antigens presented byAPC from I-E+ NOD and transferred
insulitis into I-E+ NOD mice . I-E-mediated prevention of
insulitis is thus likely to be due to the clonal deletion or anergy
of autoreactive T cells in I-E+ NOD mice rather than the
functional suppression of autoreactive T cells in an effector
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phase or impaired presentation of autoantigens by I-E+
NOD APC . If this is the case, one or a few clones among
heterogeneous autoreactive T cells may trigger autoimmune
insulitis and be deleted or inactivated by I-E molecules .
T cells expressing certainVO segments such as V017a, V#5,
V011, V012, and V#16 have been known to be deleted by
I-E molecules (25-28) . Reich et al . (29) reported that the
islet-reactive T cell clones expressing the V)135 gene segment
possibly played a key role in the development of autoimmune
insulitis in the NOD mouse. However, none of our T cell
clones expressed Vf5 . Furthermore, in vivo depletion of
V051 T cells by the mAb (MR9-4) did not affect the de-
velopment of insulitis (data not shown), suggesting that
V05' T cells may not be an essential requirement for the
development of insulitis . Two of our T cell clones, 4-1-E.2
and 4-1-G.4, expressedV#12 or V016, respectively. Northern
blot analysis of splenic T cells revealed that V016 but not
V(312 expression was significantly decreased in the disease-
resistant I-E transgenic NOD mouse, as sown in Fig. 4 .
Although our T cell clones including V016+ 4-1-G.4 could
not crossreact with I-E molecules (for example, 4-1-L.6 cells
failed to proliferate in the presence ofI-E+NOD splenocytes
without islet antigens, as shown in Fig . 1), V#16+ T cells
such as 4-1-G.4 might be similar to the case of V#11 + T
cells, which were reported to be deleted by I-E within the
thymus but not to be activated in vitro (27) . It was recently
reported that I-E expression on different subsets of im-
munocompetent cells by promoter-mutated Ea transgenis
inNOD mice was not enough to prevent insulitis (30), sug-
gesting that I-E- mediated clonal deletion might not neces-
sarily correlate with prevention ofinsulitis. Therefore, deple-
tion of V0161 T cells may address the question whether
4-1-G.4 would trigger autoimmune insulitis when mAbs to
the V016 gene product are available.
Figure 4.
￿
The VS gene expression
in various strains of mice including
NOD and I-E * NOD . Poly(A)
RNA was isolated from Con A-stimu-
lated spleen cells ofNOD, I-E' NOD,
BALB/c, and C57BL/6 (B6) . RNA
blots were hybridized with 32p-labeled
probes specific to V08.2, V012, V015,
V016, and Co .In this study, we have established islet-reactiveTcell clones
that could induce insulitis in disease-resistant I-E+ NOD
mice,anddetermined theirTCRsequences . TheseTcell clones
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